New perspectives on the treatment of premenstrual syndrome and premenstrual dysphoric disorder

@article{Eriksson2002NewPO,
  title={New perspectives on the treatment of premenstrual syndrome and premenstrual dysphoric disorder},
  author={Elias Eriksson and Jean Endicott and Bj{\"o}rn Andersch and Jules Angst and Koen Demyttenaere and Fabio Facchinetti and Mario Lanczik and Stuart Montgomery and Giovanni Muscettola and P. M. S. O'brien and John W. W. Studd and Charlotta Sundblad and A. H. Young},
  journal={Archives of Women's Mental Health},
  year={2002},
  volume={4},
  pages={111-119}
}
SummaryPremenstrual dysphoric disorder was discussed by a panel of European researchers. The criteria for diagnosis of the condition, its categorisation as a mental disorder, and its differentiation from depression and premenstrual syndrome are all considered. Data on the treatment of premenstrual dysphoric disorder, using serotonin reuptake inhibitors and other therapies, are reviewed. An algorithm for the treatment of premenstrual dysphoric disorder is proposed. 
A Comprehensive Review of Treatment Options for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
TLDR
Serotoninergic antidepressants have been established as the first-line treatment option for PMDD; however, there are a variety of additional treatment options that should be considered if a patient fails to achieve an adequate therapeutic response with a selective serotonin reuptake inhibitor.
Advances in the diagnosis of premenstrual syndrome and premenstrual dysphoric disorder.
  • L. A. Futterman
  • Medicine, Psychology
    Expert opinion on medical diagnostics
  • 2010
TLDR
The diagnostic criteria for PMS and PMDD is reviewed, some of the more common symptom diaries and other diagnostic tools used to diagnose premenstrual disorders are described, and the challenges inherent in diagnosing PMS are discussed.
Ethinyl Estradiol/Drospirenone for the Treatment of the Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder
TLDR
A combined oral contraceptive pill containing 20 μg of ethinyl estradiol and 3 mg of the progestin drospirenone in a novel dose regimen has demonstrated efficacy for the symptoms of premenstrual dysphoric disorder, a severe form of prewomen's syndrome, with an emphasis on the affective symptoms.
Update on research and treatment of premenstrual dysphoric disorder.
TLDR
Evidence suggests that individual sensitivity to cyclical variations in levels of gonadal hormones may predispose certain women to experience these mood, behavioral, and somatic symptoms in the week prior to menses.
Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.
TLDR
These guidelines present practical treatment algorithms for the use of SSRIs in women with pure PMDD or severe PMS, PMDD and underlying subsyndromal clinical features of mood or anxiety, or premenstrual exacerbation of a mood/anxiety disorder.
Premenstrual dysphoric disorder amongst Nigerian university students: prevalence, comorbid conditions, and correlates
TLDR
The rate of premenstrual dysphoric disorder in sub-Saharan African women was comparable to that in the western cultures and planning and implementing an effective strategy to manage perimenstrual problems in this region should be an issue of priority.
Premenstrual syndrome
The Efficacy of Hypericum perforatum (St John’s Wort) for the Treatment of Premenstrual Syndrome
TLDR
Daily treatment with Hypericum perforatum was more effective than placebo treatment for the most common physical and behavioural symptoms associated with PMS, and proinflammatory cytokine levels did not differ significantly between Hypericumperforatum and placebo treatment.
Psychosomatic approaches to obstetrics, gynaecology and andrology
  • M. Lal
  • Medicine, Psychology
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
  • 2009
TLDR
Clinical applications of the psychosomatic approach are discussed for various conditions including chronic pelvic pain, eating disorders, tokophobia, post-traumatic stress disorder, depression, menstrual disorders, infertility, bereavement and testicular cancer.
Síndrome premestrual (SPM): Aproximación crítica
Actualmente el mal nombrado Sindrome Premenstrual (SPM) afecta a un numero muy elevado de mujeres y aun siendo un termino injustificado, se ha convertido en parte del lenguaje cotidiano. Muchos
...
...

References

SHOWING 1-10 OF 82 REFERENCES
Medical management of premenstrual dysphoric disorder.
TLDR
Women who suffer from severe dysphoric premenstrual complaints can now be accurately diagnosed and the use of antidepressants that block the serotonin transporter, and the benzodiazepine anxiolytic alprazolam is supported.
Is premenstrual dysphoric disorder a distinct clinical entity?
TLDR
The consensus of the group was that PMDD is a distinct clinical entity and potential treatments for this disorder can now be evaluated on this basis to meet the clear need for effective therapy.
Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria.
  • E. Eriksson
  • Psychology, Medicine
    International clinical psychopharmacology
  • 1999
TLDR
The observation that the symptoms of PMD may be effectively reduced by SSRIs is of considerable clinical importance since previously no effective treatment for this common condition - apart from those disrupting ovarian cyclicity - has been available.
Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
TLDR
The comparison of 2 classes of antidepressants strongly favored the serotonergic drug, which effectively reduced symptoms and improved functioning and was well tolerated by women with severe premenstrual syndrome.
Non-antidepressant treatment of premenstrual syndrome.
TLDR
Recent preliminary trials have suggested efficacy for cognitive therapy, light therapy, and tryptophan and future studies of diet recommendations, exercise, relaxation, magnesium, nonsteroidal anti-inflammatory drugs, diuretics, opiate antagonists, and alternative therapies are needed.
Symptomatic Improvement of Premenstrual Dysphoric Disorder With Sertraline Treatment: A Randomized Controlled Trial
TLDR
Serotonin reuptake inhibitors such as sertraline are useful therapeutic options for women with premenstrual dysphoria as reflected by symptomatic improvement and change in reported functional impairment.
Treatment of premenstrual dysphoria with alprazolam. A controlled study.
TLDR
Improved study design, which addressed methodologic flaws of most previous studies of treatment outcome of "premenstrual syndrome" may account, in part, for the ability to demonstrate significant drug/placebo differences.
Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
TLDR
Serotonin reuptake inhibitors such as sertraline are useful therapeutic options for women with premenstrual dysphoria as reflected by symptomatic improvement and change in reported functional impairment.
The association between premenstrual dysphoric disorder and other mood disorders.
  • K. Yonkers
  • Psychology
    The Journal of clinical psychiatry
  • 1997
TLDR
There is an overlap in the symptoms experienced by women with PMDD and patients with other mood disorders, and some but not all antidepressants are effective in the treatment of PMDD.
The premenstrual syndrome – an equivalent of depression?
  • J. Hallman
  • Psychology, Medicine
    Acta psychiatrica Scandinavica
  • 1986
TLDR
The results suggest that severe premenstrual symptoms of predominantly depressive nature are probably a manifestation of an underlying depressive disorder.
...
...